Inhibition by noncompetitive NMDA receptor antagonists of apomorphine-induced climbing behavior in mice

Life Sciences

Volumn 58, Issue 17, 1996, Pages 1397-1402

  Kim, Hack Seang ^a   Rhee, Gyu Seek ^a   Jung, Joo Yeon ^a   Lee, Jung Hwa ^a   Jang, Choon Gon ^b   Park, Woo Kyu ^b  

^a Chungbuk National University   (South Korea)

^b Korea Research Institute of Chemical Technology   (South Korea)

Author keywords

Apomorphine; Climbing behavior; Dextromethorphan; Dextrorphan; Ketamine; MK 801

Indexed keywords

APOMORPHINE; DEXTROMETHORPHAN; DEXTRORPHAN; DIZOCILPINE; DOPAMINE RECEPTOR; GLUTAMATE RECEPTOR; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; POSTSYNAPTIC RECEPTOR; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CLIMBING; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG ANTAGONISM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALIA;

EID: 0029862731     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/0024-3205(96)00109-9     Document Type: Article

References (31)

1. B.V. CLINESCHMIDT, G.E. MARTIN, P.R. BUNTING and N.L. PAPP, Drug Dev. Res. 2 135-145 (1982).
2. H. KURIBARA, T. ASAMI, I. IDA and S. TADOKORO, Japan J. Pharmacol. 58 11-18 (1992).
3. W. DIMPFEL and M. SPULER, Psychopharmacology 101 317-323 (1990).
4. M. CARLSSON and A. CARLSSON, J. Neural Transmission 75 221-226 (1989).
5. R.B. RAFFA, M.E. ORTEGON, D.M. ROBISCH and G.E. MARTIN, Life. Sci. 44 1593-1599 (1989).
6. Y. UCHIHASHI, H. KURIBARA and S. TADOKORO, Japan J. Pharmacol. 60 25-31 (1992).
7. B. LANNES, G. MICHELETTI, J.M. WARTER, E. KEMPF and G.D. SCALA, Neurosci. Lett. 128 177-181 (1991).
8. M. BARTOLETTI, M. GAIARDI, C. GUBELLINI and M. BABBINI, Neuropharmacology 22 177-181 (1983).
9. E.D. FRENCH and G. VANTINI, Psychopharmacology 82 83-88 (1984).
10. J.R. MARTIN and A.E. TAKEMORI, Eur. J. Pharmacol. 119 75-84 (1985)
11. P. PROTAIS, J. COSTENTIN and J.C. SCHWARTZ, Psychopharmacology 50 1-6 (1976).
12. A.M. CHILDS, R.H. EVANS and J.C. WATKINS, Eur. J. Pharmacol. 145 81-86 (1988).
13. G.L. COLLINGRIDGE and R.A.J. LESTER, Pharmacol. Rev. 41 143-210 (1989).
14. J.C. WATKINS, The NMDA receptor, 2nd Edition, J.C. Watkins and G.L. Collingridge (eds),1-30, Oxford University Press, New York (1989).
15. J. COSTENTIN, P. PROTAIS and J.C. SCHWARTZ, Nature (London) 257 405-407 (1975).
16. M.F. GIORGUIEFF, M.L. KEMEL and J. GLOWINSKI, Neurosci. Lett. 6 73-77 (1977).
17. L. HEIMER, R.D. SWITZER and G.W. VAN HOESEN, J. Neurochem. 5 83-87 (1982).
18. C.J. CARTER, R. L'HEUREUX and B. SCATTON, J. Neurochem. 51 461-468 (1988).
19. B. MOGHADDAM, R.J. GUEN, R.H. ROTH, B.S. BUNNEY and R.N. ADAMS, Brain Res. 518 55-60 (1990).
20. N. SHIMIZU, S. DUAN, T. HORI and Y. OOMURA, Brain Res. Bull. 25 99-102 (1990).
21. D.W. CLOW and K. JHMANDAS, J. Pharmacol. Exp. Ther. 248 722-728 (1989).
22. L. BARBEITO, A. CHERAMY, G. GODEHEU, J.M. DESCE and J. GLOWINSKI, Eur. J. Neurosci. 2304-311 (1990).
23. J.J. BOUYER, D.H. PARK, T.H. JOH and V.M. PICKEL, Brain Res. 302 267-276 (1984).
24. T.F. FREUND, J.F. POWELL and A.D. SMITH, Neuroscience 13 1189-1216 (1984).
25. P. SOMOGYI, J.P. BOLAM and A.D. SMITH, J. Comp. Neurol. 195 567-584 (1981).
26. S. TOTTERDELL and A.D. SMITH, J. Chem. Neuroanat. 2 285-298 (1989).
27. A.D. SMITH and J.P. BOLAM, Trends Neurosci. 13 259-265 (1990).
28. L. PULVIRENTI, N.R. SWERDLOW and G.F. KOOB, Neurosci. Lett. 103 213-218 (1989).
29. A.E. KELLEY and L.C. THRONE, Brain Res. Bull. 29 247-254 (1992).
30. M.H. HAMILTON, J.S. DE BELLEROCHE, I.M. GARDINER and L.J. HERBERG, Pharmacol. Biochem. Behav. 25 943-948 (1986).
31. W.J. FREED and H.E. CANNON-SPOOR, Psychopharmacology 101 456-464 (1990).